Critical review of controversial issues in the management of advanced pediatric liver tumors

Abha A. Gupta, J. Ted Gerstle, Vicky Ng, Ansely Wong, Annie Fecteau, Marcio Malogolowkin, Rebecka L. Meyers, David Grant, Ronald M. Grant

Research output: Contribution to journalReview article

40 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra-hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease.

Original languageEnglish (US)
Pages (from-to)1013-1018
Number of pages6
JournalPediatric Blood and Cancer
Volume56
Issue number7
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

    Fingerprint

Keywords

  • Chemotherapy
  • Hepatoblastoma
  • Hepatocellular carcinoma
  • Liver transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Gupta, A. A., Gerstle, J. T., Ng, V., Wong, A., Fecteau, A., Malogolowkin, M., Meyers, R. L., Grant, D., & Grant, R. M. (2011). Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatric Blood and Cancer, 56(7), 1013-1018. https://doi.org/10.1002/pbc.22893